You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
Buccal mucosal delivery of a peptide for the treatment of autoimmune diseases
- In: SUBMITTED ORALS on Tuesday, 15 April 2014, 16:00-17:30
- At: PSWC, Melbourne (Australia) (2014)
- Type: Presentation
- By: JIN, Liang (Monash University, Pharmaceutics, Melbourne, Australia)
- Co-author(s): White, Paul (Monash University, Melbourne, Australia)
Boyd, Ben (Monash University, Melbourne, Australia)
Pennington, Mike (Peptides International, Louisville, United States of America)
Norton, Raymond (Monash University, Melbourne, Australia)
Nicolazzo, Joseph (Monash University, Melbourne, Australia) - Abstract:
Background information: As a potent blocker of the voltage-gated potassium channel Kv1.3, ShK peptide can be potentially used as an immunomodulator for the treatment of autoimmune diseases. Indeed, ShK is currently undergoing Phase I clinical trials. However, systemic delivery of ShK is challenging as oral administration leads to poor..
The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026